A. Cohenabbo et al., SERORESPONSE TO TRIVALENT ORAL POLIOVIRUS VACCINE AS A FUNCTION OF DOSAGE INTERVAL, The Pediatric infectious disease journal, 14(2), 1995, pp. 100-106
Seroresponses to trivalent oral poliovirus vaccine are not uniform thr
oughout the world. Definition of the variables that determine successf
ul immunization is vital to ensure global polio eradication. One such
variable may be dosage interval. To investigate this effect 108 infant
s were enrolled in a clinical trial and randomly assigned to receive t
hree doses of trivalent oral poliovirus vaccine (standard United State
s formulation) at 2, 3 and 4 or 2, 4 and 6 months of age. After three
doses of vaccine given before 6 months of age, immunity was virtually
complete for each of the three poliovirus types in both groups. After
two doses the seroresponse rate to each type was less with the shorter
dose interval. However the difference was not significant (P = 0.15)
in the sample size studied. Such responses differ markedly from those
seen in developing countries, where four or more doses of vaccine may
fail to provide complete protection. Differences other than dosage int
erval must contribute to those failures.